Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 25 min ago
Peer-reviewedCC BY-NCDermatology practical & conceptual

Palmoplantar Pustulosis Induced by Intravenous Anifrolumab: An Emerging Dermatologic Adverse Event?

  1. 1Department of Dermatology, Spedali Civili, University of Brescia, Brescia, Italy.
  2. 2Pathology Department, University of Brescia, ASST Spedali Civili di Brescia, Italy.

Related

  1. Acute generalized exanthematous pustulosis following nemolizumab therapy in a patient with atopic dermatitis
    David Dunaway, Emma Madigan, Jina Chung +2
    JAAD Case ReportsPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyPMC
  2. Punctate Palmoplantar Keratoderma Type 1 With a Multigenerational Family History: A Case Report
    Fernando J Medina-Olivares, Claudia Fernanda Patiño Orellana, Felix R Hernández Altamirano +1
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Dermoscopic clues for differentiating mycosis fungoides palmaris et plantaris from palmoplantar eczema.
    Sun Mun Jeong, Jong Bin Park, Hyun Jin Kim +5
    JAAD internationalPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  4. Demodex Folliculitis Following Anifrolumab Infusion.
    Hannah Bulosan, Lisa Maier, Andrea Kalus
    Dermatology practical & conceptualPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  5. Sustained multisite response to anifrolumab in refractory Chilblain lupus erythematosus.
    Sarah John, Lisabeth V Scalzi, Galen Foulke +1
    JAAD case reportsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{zanghi2026palmoplantar,
  title = {{Palmoplantar Pustulosis Induced by Intravenous Anifrolumab: An Emerging Dermatologic Adverse Event?}},
  author = {Silvia Zanghì and Stefano Bighetti and Luca Bettolini and Iacopo Ghini and Mariateresa Rossi and Vincenzo Maione},
  journal = {Dermatology practical \& conceptual},
  year = {2026},
  month = jul,
  doi = {10.5826/dpc.1603a6789},
  url = {https://europepmc.org/article/MED/42858422},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Palmoplantar Pustulosis Induced by Intravenous Anifrolumab: An Emerging Dermatologic Adverse Event?
AU  - Silvia Zanghì
AU  - Stefano Bighetti
AU  - Luca Bettolini
AU  - Iacopo Ghini
AU  - Mariateresa Rossi
AU  - Vincenzo Maione
PY  - 2026
DA  - 2026/07/31
JO  - Dermatology practical & conceptual
DO  - 10.5826/dpc.1603a6789
UR  - https://europepmc.org/article/MED/42858422
SN  - 2160-9381
ER  -